Experimental virus therapy takes on advanced tumors in early trial
Disease control
Completed
This early-phase study tested a new treatment called NG-350A, a virus designed to target tumors and boost immune activity, combined with the immunotherapy drug pembrolizumab. Fourteen people with advanced epithelial cancers that had stopped responding to standard treatments recei…
Phase: PHASE1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC